Scott joined the Board of Directors in 2019 to provide leadership and guidance to grow the overall impact of Uplifting Athletes – particularly in the rare disease research space. The University of Colorado at Denver and University of Utah School of Medicine graduate has a strong and proven record of successful non-profit board service.
A resident of Seattle, Scott is the Executive Vice President and Chief Strategy Officer for 2M Clincal. Prior to that he spent three years as Senior Vice President, Center for Rare Diseases at PRA Health Sciences, four years as Vice President, Scientific Affairs – Rare Diseases for PRA Health Sciences where he was instrumental in creating the Center For Rare Diseases, a multidisciplinary business unit focused on innovative approaches to overcome the challenges of research in rare disease populations.
Before joining 2M Clinical, Scott spent nearly a decade at PRA Health Sciences, four years with Cancer Research and Biostatistics (CRAB) as the Chief Operating Officer (COO), three years with MedSource as its Vice President, Strategic Business Development, two years as Director, Business Development for PRA International and from late 2000 until April of 2003 was the Clinical Operations Manager at Seattle Genetics, Inc.
Scott has previous non-profit Board of Directors experience with the Leukemia and Lymphoma Society, Gage Academy of Art, Lawton Wood Community and Bike Works. He’s a member of DIA’s Rare Disease Program Committee and ISCTM’s Orphan Disease Working Group and has spoken at a plethora of professional conferences including World Orphan Drug Conference, National Organization for Rare Disorders (NORD) and MassBio.
